BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s): BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.

CSE:BIOV - Post by User

BioVaxys Technology Corp.

Bullboard Posts

Post by Magnum2on Nov 07, 2020 5:30pm

261 Views

Post# 31858282

LMNGF still shows up as a U.S. trader on Barchart

The old Lions Bay U.S. symbol, however when I looked recently the BioVaxys makes no mention of a U.S. trading symbol...only Canada/BIOV and the Frankfurt/Germany trading symbol???

https://www.barchart.com/stocks/quotes/BIOV.CN/overview

Wow, not sure how I missed that....Frankfurt already shows Friday's shareprice up 30%+, perhaps Frankfurt is leading us foward...will have to watch early Monday to see if we get a further move in Europe.

https://www.boerse-frankfurt.de/equity/biovaxys-technology-corp

GLTA

Bullboard Posts

Changing Europe’s dependency on HREE from China